[ad_1]
The decision must be made quickly.
Anui Jifai, a senior Beijing official, said his proposal highlighted his expertise in research, production, marketing, and import and export of various types of vaccines, including corona. Anui Gifei’s RVD-Dimer vaccine will be valid for two years from the date of production. And the vaccine can be stored and transported from one place to another at a temperature of two to eight degrees Celsius.
Anui Gifei has already received permission for the third phase of testing on 6,000 people in Uzbekistan. And three thousand people in Indonesia and five thousand people in Malaysia will get permission to take the test. Under the preconditions of the World Health Organization, the organization will have to test the vaccine on at least 30,000 people in the third step.
Several public health experts were asked last Tuesday about China’s vaccine trial proposal. According to them, Bangladesh remains a suitable place for vaccination as the social transmission of the coronavirus continues. Once again, some countries have already started to apply the crown ticker. In this situation, a quick decision must be made by negotiating with countries and organizations that produce multiple vaccines through the third stage trial.
Bay-Nazir Ahmed, public health specialist and former director of the disease control branch of the health department The first lightWho said that the coronavirus infection has not yet decreased in Bangladesh. Despite fluctuations in the numbers, the infection continues. Therefore, considering the issue of social infection, Bangladesh is currently a suitable field for tick testing. And there is no harm without benefit if the tick is tested. He thinks that if the tick test is done in Bangladesh, it will be known how effective it will be here. In addition, the right of Bangladesh to be vaccinated will also be guaranteed.
